• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Request Membership
  • Log In
Skip to content
Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Specialties
  • Respiratory
  • Page 4
Young COPD: Prevalence and Prognostic Impact in Adults Under 50 Years
Posted inClinical Updates news Respiratory Specialties

Young COPD: Prevalence and Prognostic Impact in Adults Under 50 Years

Posted by By MedXY 08/05/2025
COPD in adults under 50 affects 4.5% of this population and is linked to increased risks of early mortality and serious cardiopulmonary events, underscoring the need for early identification and intervention.
Read More
Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD
Posted inAllergy & Immunology Clinical Updates Neurology news Psychiatry Respiratory Specialties

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD

Posted by By MedXY 08/04/2025
A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.
Read More
Ibuprofen vs. Acetaminophen: Which Fever Reducer is Right for You?
Posted inFamily Medicine & Nutrition Medical News news Pediatrics Respiratory Specialties

Ibuprofen vs. Acetaminophen: Which Fever Reducer is Right for You?

Posted by By MedXY 08/03/2025
Explore the differences, uses, and safety of ibuprofen and acetaminophen for managing fever effectively.
Read More
Targeted Pneumococcal Vaccination in New Older Adult Care Home Residents: Evidence from National Surveillance in England
Posted inClinical Updates news Public Health Respiratory Specialties

Targeted Pneumococcal Vaccination in New Older Adult Care Home Residents: Evidence from National Surveillance in England

Posted by By MedXY 08/03/2025
Vaccinating new older adult care home residents with PCV20 or PPV23 could prevent substantially more invasive pneumococcal disease cases and deaths per dose than standard age-based vaccination, supporting policy revision.
Read More
Impact of Maternal Pertussis Vaccination on Infant Immune Responses: Insights from the GaPS Trial in The Gambia
Posted inClinical Updates news Pediatrics Respiratory Specialties

Impact of Maternal Pertussis Vaccination on Infant Immune Responses: Insights from the GaPS Trial in The Gambia

Posted by By MedXY 08/02/2025
A phase 4 trial in The Gambia finds that maternal Tdap-IPV vaccination is safe and provides early infant protection, but modestly blunts immune responses to whole-cell pertussis vaccines without compromising overall immunogenicity.
Read More
Type 2 Inflammation Biomarkers and Dupilumab Response in COPD: Insights from the BOREAS Phase 3 Trial
Posted inClinical Updates Respiratory Specialties

Type 2 Inflammation Biomarkers and Dupilumab Response in COPD: Insights from the BOREAS Phase 3 Trial

Posted by By MedXY 08/02/2025
Dupilumab significantly reduced type 2 inflammation biomarkers and exacerbation risk in COPD patients with elevated eosinophils, highlighting the value of biomarker-driven therapy.
Read More
Sotatercept in High-Risk Pulmonary Arterial Hypertension: A Landmark Advance in Patient Outcomes
Posted inClinical Updates news Respiratory Specialties

Sotatercept in High-Risk Pulmonary Arterial Hypertension: A Landmark Advance in Patient Outcomes

Posted by By MedXY 08/02/2025
Sotatercept significantly reduces the risk of death, lung transplantation, or hospitalization in high-risk pulmonary arterial hypertension patients, marking a major advance in the management of this life-threatening disease.
Read More
Navigational Bronchoscopy Versus Transthoracic Needle Biopsy for Peripheral Lung Nodules: New Evidence from the VERITAS Trial
Posted inClinical Updates news Respiratory Specialties

Navigational Bronchoscopy Versus Transthoracic Needle Biopsy for Peripheral Lung Nodules: New Evidence from the VERITAS Trial

Posted by By MedXY 08/02/2025
Navigational bronchoscopy offers noninferior diagnostic accuracy to transthoracic needle biopsy for peripheral pulmonary nodules, with notably fewer pneumothorax complications.
Read More
Nerandomilast for Idiopathic and Progressive Pulmonary Fibrosis: Phase 3 Trial Insights
Posted inClinical Updates news Respiratory Specialties

Nerandomilast for Idiopathic and Progressive Pulmonary Fibrosis: Phase 3 Trial Insights

Posted by By MedXY 08/01/2025
Phase 3 trials demonstrate that nerandomilast, a selective PDE4B inhibitor, significantly slows lung function decline in idiopathic and progressive pulmonary fibrosis over 52 weeks, with manageable safety profiles.
Read More
As-Needed Albuterol–Budesonide Therapy in Mild Asthma: Clinical Impact and Comparative Evidence
Posted innews Respiratory Specialties

As-Needed Albuterol–Budesonide Therapy in Mild Asthma: Clinical Impact and Comparative Evidence

Posted by By MedXY 08/01/2025
As-needed albuterol–budesonide significantly reduces severe exacerbations in mild asthma compared to albuterol alone, with comparable safety. Two pivotal trials confirm efficacy across lung function and exacerbation outcomes.
Read More
Comparative Efficacy and Safety of Prednisone and Methotrexate as First-Line Treatments for Pulmonary Sarcoidosis
Posted innews Oncology Respiratory Specialties

Comparative Efficacy and Safety of Prednisone and Methotrexate as First-Line Treatments for Pulmonary Sarcoidosis

Posted by By MedXY 08/01/2025
A recent multicenter trial demonstrates methotrexate's noninferiority to prednisone in improving lung function at 24 weeks in pulmonary sarcoidosis, with distinct side-effect profiles informing treatment choices.
Read More
Influenza-Associated Acute Necrotizing Encephalopathy in US Children
Posted inClinical Updates Infectious Diseases Medical News Pediatrics Respiratory Specialties

Influenza-Associated Acute Necrotizing Encephalopathy in US Children

Posted by By MedXY 07/30/2025
A multicenter US study highlights the devastating burden of influenza-associated acute necrotizing encephalopathy in children, with high mortality and disability rates despite aggressive therapy, underscoring the urgent need for prevention and standardized management.
Read More
Digital Self-Management Tools Enhance Asthma Control
Posted inAllergy & Immunology Clinical Updates news Respiratory Specialties

Digital Self-Management Tools Enhance Asthma Control

Posted by By MedXY 07/30/2025
A randomized trial shows that a smartphone-based asthma self-management program improves symptom control in adults, though its effectiveness is attenuated in African American participants.
Read More
Understanding Persistent Cough in Children: Ear, Nose, and Throat Causes
Posted innews Otorhinolaryngology Respiratory Specialties

Understanding Persistent Cough in Children: Ear, Nose, and Throat Causes

Posted by By MedXY 07/27/2025
Persistent cough in children may stem from ear, nose, and throat conditions like allergic rhinitis, upper airway cough syndrome, or chronic tonsillitis.
Read More

Posts pagination

Previous page 1 2 3 4
  • Long-Term PM2.5 Exposure and Mental Health Disparities: Insights from the All of Us Research Program
  • Reducing Suicide Risk in Bipolar Disorder: The Impact of Lithium, Valproate, and Atypical Antipsychotics in Long-Term Treatment
  • Enhancing Fertility Preservation and Ovarian Function in Young Women with Breast Cancer: Insights from International Prospective Studies
  • Navigating the Frontiers of Premature Ovarian Insufficiency Research: Insights from the Top 100 Influential Articles
  • Nucleoside Reverse Transcriptase Inhibitors: A Novel Therapeutic Avenue Against Inflammaging and Age-Related Diseases
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence atrial fibrillation blood pressure breast cancer cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial depression diabetes diet epidemiology exercise gut microbiota health heart failure Hypertension immunotherapy inflammation longevity mental health metformin Mortality multiple myeloma nutrition obesity older adults Physical Activity Pregnancy prevention prognosis public health randomized clinical trial randomized controlled trial randomized trial semaglutide sexual health treatment type 2 diabetes weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top